Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection

Immunomodulatory and analgesic effects of dexamethasone are clinically well established, and this synthetic corticosteroid acts as an agonist of glucocorticoid receptors. Early results of the RECOVERY Trial from the United Kingdom and others suggest certain benefits of dexamethasone against COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Vohra, Manik, Sharma, Anu Radha, Satyamoorthy, Kapaettu, Rai, Padmalatha S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186476/
https://www.ncbi.nlm.nih.gov/pubmed/34086487
http://dx.doi.org/10.2217/pme-2020-0183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186476/
https://www.ncbi.nlm.nih.gov/pubmed/34086487
http://dx.doi.org/10.2217/pme-2020-0183

Ejemplares similares